{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T22:13:54Z","timestamp":1783203234944,"version":"3.54.6"},"reference-count":91,"publisher":"SAGE Publications","issue":"1","license":[{"start":{"date-parts":[[2022,10,25]],"date-time":"2022-10-25T00:00:00Z","timestamp":1666656000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAD"],"published-print":{"date-parts":[[2022,10,25]]},"abstract":"<jats:p>Background: The differential diagnosis of frontotemporal dementia (FTD) is still a challenging task due to its symptomatic overlap with other neurological diseases and the lack of biofluid-based biomarkers. Objective: To investigate the diagnostic potential of a combination of novel biomarkers in cerebrospinal fluid (CSF) and blood. Methods: We included 135 patients from the Center for Memory Disturbances, University of Perugia, with the diagnoses FTD (n\u200a=\u200a37), mild cognitive impairment due to Alzheimer\u2019s disease (MCI-AD, n\u200a=\u200a47), Lewy body dementia (PDD\/DLB, n\u200a=\u200a22), and cognitively unimpaired patients as controls (OND, n\u200a=\u200a29). Biomarker levels of neuronal pentraxin-2 (NPTX2), neuronal pentraxin receptor, neurofilament light (NfL) and glial fibrillary acidic protein (GFAP) were measured in CSF, as well as NfL and GFAP in serum. We assessed biomarker differences by analysis of covariance and generalized linear models (GLM). We performed receiver operating characteristics analyses and Spearman correlation to determine biomarker associations. Results: CSF NPTX2 and serum GFAP levels varied most between diagnostic groups. The combination of CSF NPTX2, serum NfL and serum GFAP differentiated FTD from the other groups with good accuracy (FTD versus MCI-AD: area under the curve (AUC) [95% CI]\u200a=\u200a0.89 [0.81\u20130.96]; FTD versus PDD\/DLB: AUC\u200a=\u200a0.82 [0.71\u20130.93]; FTD versus OND: AUC\u200a=\u200a0.80 [0.70\u20130.91]). CSF NPTX2 and serum GFAP correlated positively only in PDD\/DLB (\u03c1=\u200a0.56, p\u200a&lt;\u200a0.05). NPTX2 and serum NfL did not correlate in any of the diagnostic groups. Serum GFAP and serum NfL correlated positively in all groups (\u03c1=\u200a0.47\u20130.74, p\u200a&lt;\u200a0.05). Conclusion: We show the combined potential of CSF NPTX2, serum NfL, and serum GFAP to differentiate FTD from other neurodegenerative disorders.<\/jats:p>","DOI":"10.3233\/jad-220318","type":"journal-article","created":{"date-parts":[[2022,9,16]],"date-time":"2022-09-16T13:56:12Z","timestamp":1663336572000},"page":"363-380","source":"Crossref","is-referenced-by-count":31,"title":["A Combination of Neurofilament Light, Glial Fibrillary Acidic Protein, and Neuronal Pentraxin-2 Discriminates Between Frontotemporal Dementia and Other Dementias"],"prefix":"10.1177","volume":"90","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3116-7789","authenticated-orcid":false,"given":"Katharina","family":"Bolsewig","sequence":"first","affiliation":[{"name":"Department of Clinical Chemistry, Neuro chemistry Laboratory and Biobank, Amsterdam Neuroscience, Amsterdam UMC, VU University, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9713-116X","authenticated-orcid":false,"given":"Yanaika S.","family":"Hok-A-Hin","sequence":"additional","affiliation":[{"name":"Department of Clinical Chemistry, Neuro chemistry Laboratory and Biobank, Amsterdam Neuroscience, Amsterdam UMC, VU University, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica N.","family":"Sepe","sequence":"additional","affiliation":[{"name":"Department of Clinical Chemistry, Neuro chemistry Laboratory and Biobank, Amsterdam Neuroscience, Amsterdam UMC, VU University, The Netherlands"},{"name":"Department of Medicine and Surgery, Laboratory of Clinical Neuro chemistry, University of Perugia, Perugia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2200-0832","authenticated-orcid":false,"given":"Lynn","family":"Boonkamp","sequence":"additional","affiliation":[{"name":"Department of Clinical Chemistry, Neuro chemistry Laboratory and Biobank, Amsterdam Neuroscience, Amsterdam UMC, VU University, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Jacobs","sequence":"additional","affiliation":[{"name":"ADx Neuro Sciences, Ghent, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0456-5650","authenticated-orcid":false,"given":"Giovanni","family":"Bellomo","sequence":"additional","affiliation":[{"name":"Department of Medicine and Surgery, Laboratory of Clinical Neuro chemistry, University of Perugia, Perugia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9623-1900","authenticated-orcid":false,"given":"Federico Paolini","family":"Paoletti","sequence":"additional","affiliation":[{"name":"Department of Medicine and Surgery, Laboratory of Clinical Neuro chemistry, University of Perugia, Perugia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9466-5366","authenticated-orcid":false,"given":"Eugeen","family":"Vanmechelen","sequence":"additional","affiliation":[{"name":"ADx Neuro Sciences, Ghent, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4061-0837","authenticated-orcid":false,"given":"Charlotte E.","family":"Teunissen","sequence":"additional","affiliation":[{"name":"Department of Clinical Chemistry, Neuro chemistry Laboratory and Biobank, Amsterdam Neuroscience, Amsterdam UMC, VU University, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5722-3967","authenticated-orcid":false,"given":"Lucilla","family":"Parnetti","sequence":"additional","affiliation":[{"name":"Department of Medicine and Surgery, Laboratory of Clinical Neuro chemistry, University of Perugia, Perugia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9140-4243","authenticated-orcid":false,"given":"Eline A. J.","family":"Willemse","sequence":"additional","affiliation":[{"name":"Department of Clinical Chemistry, Neuro chemistry Laboratory and Biobank, Amsterdam Neuroscience, Amsterdam UMC, VU University, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"key":"10.3233\/JAD-220318_ref1","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1136\/jnnp.2010.212225","article-title":"Clinical, genetic and pathological heterogeneity of frontotemporal dementia: A review","volume":"82","author":"Seelaar","year":"2011","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.3233\/JAD-220318_ref2","doi-asserted-by":"crossref","first-page":"f4827","DOI":"10.1136\/bmj.f4827","article-title":"Clinical review. Frontotemporal dementia","volume":"347","author":"Warren","year":"2013","journal-title":"BMJ"},{"key":"10.3233\/JAD-220318_ref3","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1177\/2045125317739818","article-title":"Frontotemporal dementia: Latest evidence and clinical implications","volume":"8","author":"Young","year":"2018","journal-title":"Ther Adv Psychopharmacol"},{"key":"10.3233\/JAD-220318_ref4","doi-asserted-by":"crossref","first-page":"504","DOI":"10.3389\/fneur.2018.00504","article-title":"CSF biomarkers of neurodegeneration in progressive non-fluent aphasia and other forms of frontotemporal dementia: Clues for pathomechanisms?","volume":"9","author":"Kortvelyessy","year":"2018","journal-title":"Front Neurol"},{"key":"10.3233\/JAD-220318_ref5","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/S1474-4422(05)70223-4","article-title":"Frontotemporal dementia","volume":"4","author":"Neary","year":"2005","journal-title":"Lancet Neurol"},{"key":"10.3233\/JAD-220318_ref6","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1212\/WNL.58.11.1615","article-title":"The prevalence offrontotemporal dementia","volume":"58","author":"Ratnavalli","year":"2002","journal-title":"Neurology"},{"key":"10.3233\/JAD-220318_ref7","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1093\/brain\/awh598","article-title":"The evolution and pathology of frontotemporal dementia","volume":"128","author":"Kertesz","year":"2005","journal-title":"Brain"},{"key":"10.3233\/JAD-220318_ref8","first-page":"267","article-title":"Frontotemporal Dementia (FTD) - even with revisited criteria a diagnostic challenge","volume":"82","author":"Luscher","year":"2014","journal-title":"Fortschr Neurol Psychiatr"},{"key":"10.3233\/JAD-220318_ref9","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1093\/brain\/awaa018","article-title":"Recommendations to distinguish behavioural variant frontotemporal dementia from psychiatric disorders","volume":"143","author":"Ducharme","year":"2020","journal-title":"Brain"},{"key":"10.3233\/JAD-220318_ref10","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1212\/01.wnl.0000191304.55196.4d","article-title":"A systematic review of neurotransmitter deficits and treatments in frontotemporal dementia","volume":"66","author":"Huey","year":"2006","journal-title":"Neurology"},{"key":"10.3233\/JAD-220318_ref11","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","article-title":"The diagnosis of dementia due to Alzheimer\u2019s disease: Recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease","volume":"7","author":"McKhann","year":"2011","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-220318_ref12","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"NIA-AA Research Framework: Toward a biological definition of Alzheimer\u2019s disease","volume":"14","author":"Jack","year":"2018","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-220318_ref13","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1038\/s41591-021-01382-x","article-title":"Biomarkers for neurodegenerative diseases","volume":"27","author":"Hansson","year":"2021","journal-title":"Nat Med"},{"key":"10.3233\/JAD-220318_ref14","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.1093\/brain\/awv181","article-title":"Cerebrospinal fluid tau and amyloid-beta1-42 in patients with dementia","volume":"138","author":"Skillback","year":"2015","journal-title":"Brain"},{"key":"10.3233\/JAD-220318_ref15","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.dadm.2015.12.004","article-title":"Novel diagnostic cerebrospinal fluid biomarkers for pathologic subtypes of frontotemporal dementia identified by proteomics","volume":"2","author":"Teunissen","year":"2016","journal-title":"Alzheimers Dement (Amst)"},{"key":"10.3233\/JAD-220318_ref16","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.bbapap.2014.12.010","article-title":"Cerebrospinal fluid proteomics and protein biomarkers in frontotemporal lobar degeneration: Current status and future perspectives","volume":"1854","author":"Oeckl","year":"2015","journal-title":"Biochim Biophys Acta"},{"key":"10.3233\/JAD-220318_ref17","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/nan.12530","article-title":"Review: Fluid biomarkers for frontotemporal dementias","volume":"45","author":"Zetterberg","year":"2019","journal-title":"Neuropathol Appl Neurobiol"},{"key":"10.3233\/JAD-220318_ref18","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1002\/acn3.629","article-title":"Novel CSF biomarkers to discriminate FTLD and its pathological subtypes","volume":"5","author":"Del Campo","year":"2018","journal-title":"Ann Clin Transl Neurol"},{"key":"10.3233\/JAD-220318_ref19","doi-asserted-by":"crossref","first-page":"244","DOI":"10.3390\/brainsci11020244","article-title":"Blood biomarkers in frontotemporal dementia: Review and meta-analysis","volume":"11","author":"Ntymenou","year":"2021","journal-title":"Brain Sci"},{"key":"10.3233\/JAD-220318_ref21","doi-asserted-by":"publisher","DOI":"10.1002\/alz.12643"},{"key":"10.3233\/JAD-220318_ref22","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1002\/acn3.745","article-title":"Novel CSF biomarkers in genetic frontotemporal dementia identified by proteomics","volume":"6","author":"van der Ende","year":"2019","journal-title":"Ann Clin Transl Neurol"},{"key":"10.3233\/JAD-220318_ref23","doi-asserted-by":"crossref","first-page":"e1231","DOI":"10.1212\/WNL.0000000000005261","article-title":"Clinical value of neurofilament and phospho-tau\/tau ratio in the frontotemporal dementia spectrum","volume":"90","author":"Meeter","year":"2018","journal-title":"Neurology"},{"key":"10.3233\/JAD-220318_ref24","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/1471-2377-13-54","article-title":"Cerebrospinal fluid neurofilament light chain protein levels in subtypes of frontotemporal dementia","volume":"13","author":"Landqvist Waldo","year":"2013","journal-title":"BMC Neurol"},{"key":"10.3233\/JAD-220318_ref25","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1136\/jnnp-2015-312972","article-title":"Neurofilament light chain in FTD is elevated not only in cerebrospinal fluid, but also in serum","volume":"87","author":"Wilke","year":"2016","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.3233\/JAD-220318_ref26","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1001\/jamaneurol.2019.1534","article-title":"Diagnostic value of cerebrospinal fluid neurofilament light protein in neurology: A systematic review and meta-analysis","volume":"76","author":"Bridel","year":"2019","journal-title":"JAMA Neurol"},{"key":"10.3233\/JAD-220318_ref27","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1212\/WNL.54.10.1960","article-title":"Cytoskeleton proteins in CSF distinguish frontotemporal dementia from AD","volume":"54","author":"Sjogren","year":"2000","journal-title":"Neurology"},{"key":"10.3233\/JAD-220318_ref28","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.3233\/JAD-200608","article-title":"Serum glial fibrillary acidic protein (GFAP) is a marker of disease severity in frontotemporal lobar degeneration","volume":"77","author":"Benussi","year":"2020","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-220318_ref29","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.neulet.2014.01.055","article-title":"Role of GFAP in CNS injuries","volume":"565","author":"Brenner","year":"2014","journal-title":"Neurosci Lett"},{"key":"10.3233\/JAD-220318_ref30","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.tins.2015.04.003","article-title":"Glial fibrillary acidic protein: From intermediate filament assembly and gliosis to neurobiomarker","volume":"38","author":"Yang","year":"2015","journal-title":"Trends Neurosci"},{"key":"10.3233\/JAD-220318_ref31","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1093\/brain\/awh250","article-title":"Astrocytic degeneration relates to the severity of disease in frontotemporal dementia","volume":"127","author":"Broe","year":"2004","journal-title":"Brain"},{"key":"10.3233\/JAD-220318_ref32","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1111\/jnc.13399","article-title":"Glial fibrillar acidic protein in the cerebrospinal fluid of Alzheimer\u2019s disease, dementia with Lewy bodies, and frontotemporal lobar degeneration","volume":"136","author":"Ishiki","year":"2016","journal-title":"J Neurochem"},{"key":"10.3233\/JAD-220318_ref33","doi-asserted-by":"crossref","first-page":"481","DOI":"10.3233\/JAD-180325","article-title":"Glial fibrillary acidic protein in serum is increased in Alzheimer\u2019s disease and correlates with cognitive impairment","volume":"67","author":"Oeckl","year":"2019","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-220318_ref34","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.bbr.2018.02.015","article-title":"Neuroinflammation in Alzheimer\u2019s disease: Pleiotropic roles for cytokines and neuronal pentraxins","volume":"347","author":"Swanson","year":"2018","journal-title":"Behav Brain Res"},{"key":"10.3233\/JAD-220318_ref35","doi-asserted-by":"crossref","first-page":"575","DOI":"10.3389\/fncel.2019.00575","article-title":"The role of neuronal pentraxin 2 (NP2) in regulating glutamatergic signaling and neuropathology","volume":"13","author":"Chapman","year":"2019","journal-title":"Front Cell Neurosci"},{"key":"10.3233\/JAD-220318_ref36","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s00702-021-02411-2","article-title":"Neuronal pentraxins as biomarkers of synaptic activity: From physiological functions to pathological changes in neurodegeneration","volume":"129","author":"Gomez de San Jose","year":"2022","journal-title":"J Neural Transm (Vienna)"},{"key":"10.3233\/JAD-220318_ref37","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1523\/JNEUROSCI.2768-16.2016","article-title":"Presynaptic neuronal pentraxin receptor organizes excitatory and inhibitory synapses","volume":"37","author":"Lee","year":"2017","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-220318_ref38","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.neuron.2016.04.024","article-title":"Pentraxins coordinate excitatory synapse maturation and circuit integration of parvalbumin interneurons","volume":"90","author":"Pelkey","year":"2016","journal-title":"Neuron"},{"key":"10.3233\/JAD-220318_ref39","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.coi.2005.11.009","article-title":"Pentraxins as a key component of innate immunity","volume":"18","author":"Bottazzi","year":"2006","journal-title":"Curr Opin Immunol"},{"key":"10.3233\/JAD-220318_ref40","first-page":"216","article-title":"Pentraxins in innate immunity and inflammation. , 80-86; discussion 86-91","volume":"279","author":"Garlanda","year":"2006","journal-title":"Novartis Found Symp"},{"key":"10.3233\/JAD-220318_ref41","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s13024-020-00388-2","article-title":"Identification of novel cerebrospinal fluid biomarker candidates for dementia with Lewy bodies: A proteomic approach","volume":"15","author":"van Steenoven","year":"2020","journal-title":"Mol Neurodegener"},{"key":"10.3233\/JAD-220318_ref42","doi-asserted-by":"crossref","first-page":"e1800105","DOI":"10.1002\/prca.201800105","article-title":"Quantitative proteomic profiling of cerebrospinal fluid to identify candidate biomarkers for Alzheimer\u2019s disease","volume":"13","author":"Sathe","year":"2019","journal-title":"Proteomics Clin Appl"},{"key":"10.3233\/JAD-220318_ref43","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1136\/jnnp-2019-322493","article-title":"Neuronalpentraxin 2: A synapse-derived CSF biomarker in geneticfrontotemporal dementia","volume":"91","author":"van der Ende","year":"2020","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.3233\/JAD-220318_ref44","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1136\/jnnp-2020-323520","article-title":"Fluid biomarkers in frontotemporal dementia: Past, present and future","volume":"92","author":"Swift","year":"2021","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.3233\/JAD-220318_ref45","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.trci.2019.11.002","article-title":"Synaptic biomarkers in CSF aid in diagnosis, correlate with cognition and predict progression in MCI and Alzheimer\u2019s disease","volume":"5","author":"Galasko","year":"2019","journal-title":"Alzheimers Dement (N Y)"},{"key":"10.3233\/JAD-220318_ref46","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1212\/WNL.0000000000004058","article-title":"Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium","volume":"89","author":"McKeith","year":"2017","journal-title":"Neurology"},{"key":"10.3233\/JAD-220318_ref47","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1001\/archpsyc.1983.01790060110016","article-title":"The Mini-Mental State Examination","volume":"40","author":"Folstein","year":"1983","journal-title":"Arch Gen Psychiatry"},{"key":"10.3233\/JAD-220318_ref48","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jalz.2011.03.008","article-title":"The diagnosis of mild cognitive impairment due to Alzheimer\u2019s disease: Recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease","volume":"7","author":"Albert","year":"2011","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-220318_ref49","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1002\/mds.26424","article-title":"MDS clinical diagnostic criteria for Parkinson\u2019s disease","volume":"30","author":"Postuma","year":"2015","journal-title":"Mov Disord"},{"key":"10.3233\/JAD-220318_ref50","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1212\/WNL.51.6.1546","article-title":"Frontotemporal lobar degeneration: A consensus on clinical diagnostic criteria","volume":"51","author":"Neary","year":"1998","journal-title":"Neurology"},{"key":"10.3233\/JAD-220318_ref51","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1093\/brain\/awr179","article-title":"Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia","volume":"134","author":"Rascovsky","year":"2011","journal-title":"Brain"},{"key":"10.3233\/JAD-220318_ref52","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1002\/mds.21507","article-title":"Clinical diagnostic criteria for dementia associated with Parkinson\u2019s disease","volume":"22","author":"Emre","year":"2007","journal-title":"Mov Disord"},{"key":"10.3233\/JAD-220318_ref53","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1212\/WNL.0b013e3181c47cc2","article-title":"A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking","volume":"73","author":"Teunissen","year":"2009","journal-title":"Neurology"},{"key":"10.3233\/JAD-220318_ref54","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3389\/fneur.2015.00179","article-title":"A practical guide to immunoassay method validation","volume":"6","author":"Andreasson","year":"2015","journal-title":"Front Neurol"},{"key":"10.3233\/JAD-220318_ref58","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1002\/bimj.200810425","article-title":"Simultaneous inference in general parametric models","volume":"50","author":"Hothorn","year":"2008","journal-title":"Biom J"},{"key":"10.3233\/JAD-220318_ref59","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/1471-2105-12-77","article-title":"pROC: An open-source package for R and S+ to analyze and compare ROC curves","volume":"12","author":"Robin","year":"2011","journal-title":"BMC Bioinformatics"},{"key":"10.3233\/JAD-220318_ref60","doi-asserted-by":"crossref","first-page":"e75091","DOI":"10.1371\/journal.pone.0075091","article-title":"Increased neurofilament light chain blood levels in neurodegenerative neurological diseases","volume":"8","author":"Gaiottino","year":"2013","journal-title":"PLoS One"},{"key":"10.3233\/JAD-220318_ref61","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.dadm.2019.08.009","article-title":"The diagnostic performance of neurofilament light chain in CSF and blood for Alzheimer\u2019s disease, frontotemporal dementia, and amyotrophic lateral sclerosis: A systematic review and meta-analysis","volume":"11","author":"Forgrave","year":"2019","journal-title":"Alzheimers Dement (Amst)"},{"key":"10.3233\/JAD-220318_ref62","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.neulet.2014.01.014","article-title":"Astrogliosis as a therapeutic target for neurodegenerative diseases","volume":"565","author":"Colangelo","year":"2014","journal-title":"Neurosci Lett"},{"key":"10.3233\/JAD-220318_ref63","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s13024-021-00433-8","article-title":"Altered network properties in C9ORF72 repeat expansion cortical neurons are due to synaptic dysfunction","volume":"16","author":"Perkins","year":"2021","journal-title":"Mol Neurodegener"},{"key":"10.3233\/JAD-220318_ref64","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/s41582-019-0231-z","article-title":"Neuroinflammation in frontotemporal dementia","volume":"15","author":"Bright","year":"2019","journal-title":"Nat Rev Neurol"},{"key":"10.3233\/JAD-220318_ref65","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.brainres.2018.02.011","article-title":"Synaptic dysfunction and altered excitability in C9ORF72 ALS\/FTD","volume":"1693","author":"Starr","year":"2018","journal-title":"Brain Res"},{"key":"10.3233\/JAD-220318_ref66","doi-asserted-by":"crossref","first-page":"3250","DOI":"10.1172\/JCI90607","article-title":"Microglia and C9orf72 in neuroinflammation and ALS and frontotemporal dementia","volume":"127","author":"Lall","year":"2017","journal-title":"J Clin Invest"},{"key":"10.3233\/JAD-220318_ref67","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s00401-007-0309-3","article-title":"Neuronal pentraxin II is highly upregulated in Parkinson\u2019s disease and a novel component of Lewy bodies","volume":"115","author":"Moran","year":"2008","journal-title":"Acta Neuropathol"},{"key":"10.3233\/JAD-220318_ref68","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s12974-020-1723-x","article-title":"Frontal cortex chitinase and pentraxin neuroinflammatory alterations during the progression of Alzheimer\u2019s disease","volume":"17","author":"Moreno-Rodriguez","year":"2020","journal-title":"J Neuroinflammation"},{"key":"10.3233\/JAD-220318_ref69","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.bbi.2016.07.148","article-title":"Neuronal Pentraxin 2 predicts medial temporal atrophy and memory decline across the Alzheimer\u2019s disease spectrum","volume":"58","author":"Swanson","year":"2016","journal-title":"Brain Behav Immun"},{"key":"10.3233\/JAD-220318_ref70","doi-asserted-by":"crossref","first-page":"135078","DOI":"10.1016\/j.neulet.2020.135078","article-title":"Decreased cerebrospinal fluid neuronal pentraxin receptor is associated with PET-Abeta load and cerebrospinal fluid Abeta in a pilot study of Alzheimer\u2019s disease","volume":"731","author":"Lim","year":"2020","journal-title":"Neurosci Lett"},{"key":"10.3233\/JAD-220318_ref71","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1523\/JNEUROSCI.4564-06.2007","article-title":"Presynaptic alpha-synuclein aggregates, not Lewy bodies, cause neurodegeneration in dementia with Lewy bodies","volume":"27","author":"Kramer","year":"2007","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-220318_ref72","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3390\/cells10010038","article-title":"Pathologically decreased CSF levels of synaptic marker NPTX2 in DLB are correlated with levels of alpha-synuclein and VGF","volume":"10","author":"Boiten","year":"2020","journal-title":"Cells"},{"key":"10.3233\/JAD-220318_ref73","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1212\/WNL.0000000000001015","article-title":"CSF neurofilament light differs in neurodegenerative diseases and predicts severity and survival","volume":"83","author":"Skillback","year":"2014","journal-title":"Neurology"},{"key":"10.3233\/JAD-220318_ref74","doi-asserted-by":"crossref","first-page":"e1390","DOI":"10.1212\/WNL.0000000000006318","article-title":"Serum neurofilament light chain in behavioral variant frontotemporal dementia","volume":"91","author":"Steinacker","year":"2018","journal-title":"Neurology"},{"key":"10.3233\/JAD-220318_ref75","doi-asserted-by":"crossref","first-page":"3505","DOI":"10.1093\/brain\/awab223","article-title":"Plasma GFAP is an early marker of amyloid-beta but not tau pathology in Alzheimer\u2019s disease","volume":"144","author":"Pereira","year":"2021","journal-title":"Brain"},{"key":"10.3233\/JAD-220318_ref76","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41398-020-01137-1","article-title":"Plasma glial fibrillary acidic protein is elevated in cognitively normal older adults at risk of Alzheimer\u2019s disease","volume":"11","author":"Chatterjee","year":"2021","journal-title":"Transl Psychiatry"},{"key":"10.3233\/JAD-220318_ref77","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s13195-020-00682-7","article-title":"Combination of plasma amyloidbeta(1-42\/1-40) and glial fibrillary acidic protein stronglyassociates with cerebral amyloid pathology","volume":"12","author":"Verberk","year":"2020","journal-title":"Alzheimers ResTher"},{"key":"10.3233\/JAD-220318_ref78","first-page":"1471","article-title":"Differencesbetween plasma and cerebrospinal fluid glial fibrillary acidicprotein levels across the Alzheimer Disease Continuum","volume":"78","author":"Benedet Al","year":"2021","journal-title":"JAMANeurol"},{"key":"10.3233\/JAD-220318_ref79","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2021-328547"},{"key":"10.3233\/JAD-220318_ref80","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1002\/glia.23924","article-title":"Astrocytes in the regulation of cerebrovascular functions","volume":"69","author":"Cohen-Salmon","year":"2021","journal-title":"Glia"},{"key":"10.3233\/JAD-220318_ref81","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nrneurol.2017.188","article-title":"Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders","volume":"14","author":"Sweeney","year":"2018","journal-title":"Nat Rev Neurol"},{"key":"10.3233\/JAD-220318_ref82","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1042\/CS20171634","article-title":"The pericyte-glia interface at the blood-brain barrier","volume":"132","author":"Giannoni","year":"2018","journal-title":"Clin Sci (Lond)"},{"key":"10.3233\/JAD-220318_ref83","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2020-325085"},{"key":"10.3233\/JAD-220318_ref84","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1136\/jnnp-2019-321954","article-title":"Plasma glial fibrillary acidic protein is raised in progranulin-associated frontotemporal dementia","volume":"91","author":"Heller","year":"2020","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.3233\/JAD-220318_ref85","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s11910-015-0531-7","article-title":"The role of neuroinflammation in dementias","volume":"15","author":"Pasqualetti","year":"2015","journal-title":"Curr Neurol Neurosci Rep"},{"key":"10.3233\/JAD-220318_ref86","doi-asserted-by":"crossref","first-page":"20130595","DOI":"10.1098\/rstb.2013.0595","article-title":"Astroglial cradle in the life of the synapse","volume":"369","author":"Verkhratsky","year":"2014","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"10.3233\/JAD-220318_ref87","doi-asserted-by":"crossref","first-page":"a020420","DOI":"10.1101\/cshperspect.a020420","article-title":"Astrogliosis","volume":"7","author":"Sofroniew","year":"2014","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"10.3233\/JAD-220318_ref88","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/s41591-018-0304-3","article-title":"Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer\u2019s disease","volume":"25","author":"Preische","year":"2019","journal-title":"Nat Med"},{"key":"10.3233\/JAD-220318_ref89","doi-asserted-by":"crossref","first-page":"e1479","DOI":"10.1212\/WNL.0000000000007179","article-title":"Serum NFL discriminates Parkinson disease from atypical parkinsonisms","volume":"92","author":"Marques","year":"2019","journal-title":"Neurology"},{"key":"10.3233\/JAD-220318_ref90","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1001\/jamaneurol.2018.0118","article-title":"A 2-step cerebrospinal algorithm for the selection of frontotemporal lobar degeneration subtypes","volume":"75","author":"Lleo","year":"2018","journal-title":"JAMA Neurol"},{"key":"10.3233\/JAD-220318_ref91","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s00401-012-0983-7","article-title":"CSF biomarkers cutoffs: The importance of coincident neuropathological diseases","volume":"124","author":"Toledo","year":"2012","journal-title":"Acta Neuropathol"},{"key":"10.3233\/JAD-220318_ref92","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s40035-021-00275-w","article-title":"Plasma glial fibrillary acidic protein and neurofilament light chainfor the diagnostic and prognostic evaluation of frontotemporaldementia","volume":"10","author":"Zhu","year":"2021","journal-title":"Transl Neurodegener"},{"key":"10.3233\/JAD-220318_ref93","doi-asserted-by":"crossref","first-page":"97 e91","DOI":"10.1016\/j.neurobiolaging.2020.03.013","article-title":"Cerebrospinal fluid neuronal pentraxin receptor as a biomarker of long-term progression of Alzheimer\u2019s disease: A 24-month follow-up study","volume":"93","author":"Lim","year":"2020","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-220318_ref94","doi-asserted-by":"crossref","first-page":"4575","DOI":"10.3390\/jcm10194575","article-title":"Neurogranin and neuronal pentraxin receptor as synaptic dysfunction biomarkers in Alzheimer\u2019s disease","volume":"10","author":"Dulewicz","year":"2021","journal-title":"J Clin Med"},{"key":"10.3233\/JAD-220318_ref95","doi-asserted-by":"crossref","first-page":"e01779","DOI":"10.1002\/brb3.1779","article-title":"Association between serum NPTX2 and cognitive function in patients with vascular dementia","volume":"10","author":"Shao","year":"2020","journal-title":"{Brain Behav"}],"container-title":["Journal of Alzheimer's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JAD-220318","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T10:07:27Z","timestamp":1777370847000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JAD-220318"}},"subtitle":[],"editor":[{"given":"Bettina","family":"Platt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2022,10,25]]},"references-count":91,"journal-issue":{"issue":"1"},"URL":"https:\/\/doi.org\/10.3233\/jad-220318","relation":{},"ISSN":["1387-2877","1875-8908"],"issn-type":[{"value":"1387-2877","type":"print"},{"value":"1875-8908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,25]]}}}